1. Home
  2. TAYD vs PLX Comparison

TAYD vs PLX Comparison

Compare TAYD & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$55.70

Market Cap

193.6M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.56

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
PLX
Founded
1955
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
207.1M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
TAYD
PLX
Price
$55.70
$2.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.6K
★ 836.2K
Earning Date
10-02-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
0.14
★ 0.27
Revenue
$41,649,673.00
★ $52,744,000.00
Revenue This Year
$25.09
$55.77
Revenue Next Year
$23.22
N/A
P/E Ratio
$403.00
★ $9.46
Revenue Growth
N/A
★ N/A
52 Week Low
$43.14
$1.65
52 Week High
$90.37
$3.19

Technical Indicators

Market Signals
Indicator
TAYD
PLX
Relative Strength Index (RSI) 44.85 42.44
Support Level $51.63 $2.21
Resistance Level $59.69 $2.75
Average True Range (ATR) 1.89 0.10
MACD -0.20 -0.02
Stochastic Oscillator 42.70 19.67

Price Performance

Historical Comparison
TAYD
PLX

About TAYD Taylor Devices Inc.

Taylor Devices Inc is engaged in the design, development, manufacture and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment and structures. The company continues to develop new and technology products. The company manufactures and sells a group of very similar products that have many different applications for customers. These similar products are included in one of nine categories, namely, Seismic Dampers, Fluidicshoks, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators. It has presence in USA, Asia, and Others. Majority of revenue comes from USA.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: